SPH | Briefing, News, Analysis, Research, Data

SPH

A national pharmaceutical industry group headquartered in Shanghai

Shanghai Pharmaceutical Group Corporation Limited (the Company) (HKSE stock code: 02607; SSE stock code: 601607) is a national pharmaceutical industry group headquartered in Shanghai. The Company's main business covers pharmaceutical research and development and manufacturing, distribution and retailing, with an operating income of 105.5 billion yuan in 2015, the Company's overall ranking is among the best in China, and it is one of the few listed pharmaceutical companies in China with a leading position in both the pharmaceutical products and distribution markets, selected as a sample stock of the SSE 180 Index and the CSI 300 Index, and its H shares are selected as a constituent stock of the Hang Seng Index, a constituent stock of the Morgan Stanley China Index ( (MSCI).

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Jan 18, 1994

HQ location

Shanghai, China

Legal name

Shanghai Pharmaceuticals Holding Co., Ltd.

Website

http://www.sphchina.com/

pharm@sphchina.com

Employees

10001-50000

All
News
Analysis
Research

Briefing May 24, 2022 09:04 AM · Financials

Xuancheng, Anhui: the upper limit of the unified provident fund loan is 500000 yuan, and the number of talents is increased by 100000 yuan

Briefing May 11, 2022 09:55 AM · Technology | Healthcare | Financials

The suggested retail price of all models of Volkswagen brand will be increased: the price of new energy models will be increased by 3000 yuan to 5000 yuan

In-depth

Healthcare

Chinese Company Turned the Tables on Domestic Cell Culture Media Market

In this article, EqualOcean mainly introduce the history, competition, lead company, future trend in domestic cell culture media industry.

Feb 02, 2023 10:45 AM

Briefing Apr 19, 2022 08:14 AM · Consumer Staples | Healthcare

361 degrees announced that the retail sales of main brand products in the first quarter recorded a high double-digit growth year-on-year.

Briefing Mar 14, 2022 05:39 PM · Technology | Consumer Discretionary | Healthcare

Shanghai Pharmaceutical: the application for non-public offering of a shares was approved by the CSRC

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Technology, Healthcare, Financials

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Briefing Mar 11, 2022 05:29 PM · Technology | Consumer Staples | Healthcare

Shanghai Pharmaceutical: Methotrexate tablets pass the consistency evaluation of generic drugs

Briefing Mar 01, 2022 05:30 PM · Communication | Financials | Automotive

Shanghai Pharmaceutical announcement that amiodarone hydrochloride tablets passed the consistency evaluation of generic drugs.

Briefing Feb 11, 2022 05:20 PM · Technology | Consumer Staples | Healthcare

Shanghai Pharmaceutical: the subsidiary amiodarone hydrochloride injection was approved for production

Briefing Jan 28, 2022 04:29 PM · Technology | Consumer Staples | Healthcare

Yiming food: the subsidiary is licensed to use the logo of Jiangsu student drinking milk

Healthcare

HealthGuard: Registration of Indonesian Subsidiary, Investment in Producing HPV Vaccine

Jun 20, 2024 03:12 PM

Healthcare

SINOVAC Plans to Invest USD 100 Mn in Brazil Starting This Year

EqualOcean has learned that on June 4, Vice President of the Federative Republic of Brazil and Minister of Development, Industry, Trade, and Services, Geraldo Alckmin, met with SINOVAC(科兴) Chairman, President, and CEO Yin Weidong(尹卫东) in Beijing.

Jun 06, 2024 06:18 PM

Briefing Jan 19, 2022 04:59 PM · Technology | Healthcare | Real Estate

Jujie micro fiber: the net profit in 2021 will increase by 365% - 502% year-on-year

Briefing Jan 11, 2022 04:48 PM · Technology | Healthcare

Financial Associated Press, January 11 - CNOOC expects a net output of 600 to 610 million barrels of oil equivalent in 2022.

Briefing Dec 20, 2021 04:39 PM · Technology | Consumer Discretionary | Healthcare

Dingsheng new material: it is proposed to temporarily supplement working capital with idle raised funds of no more than 170 million yuan

Healthcare

Yilite Technology Completes A+ Round Financing of CNY 100 Million

Yilite Technology has secured over CNY 100 million in two rounds of financing within the year.

May 15, 2024 03:21 PM

Healthcare

Cellatopia Secures Nearly CNY Ten Mn in Seed Funding

EqualOcean has learned that Cellatopia(喜同生物), a biotechnology company based in Suzhou, recently announced the successful securing of nearly CNY ten million in seed funding. The funding was primarily led by Suzhou Shishangbai Venture Capital(苏州石上柏创业合伙企业) and followed by institutions such as Suzhou Nuowei Venture Investment Limited(苏州诺为创业投资有限公司).

Apr 18, 2024 01:25 PM

Briefing Dec 15, 2021 08:19 PM · Technology | Consumer Discretionary | Healthcare

The revised version of the detailed rules of the standards for the audit of network short video content was released

Briefing Dec 10, 2021 04:29 PM · Technology | Consumer Staples | Healthcare

Kaisheng new material: at present, thionyl chloride is basically in full production and full sales

Briefing Jul 19, 2021 04:38 PM

Fitch confirmed that Wanzhou International, the parent company of Shuanghui, is rated as' BBB + 'with a stable outlook.

Briefing Jul 16, 2021 05:33 PM · Technology | Consumer Staples | Healthcare

Minde Electronics: it is planned to raise no more than 500 million yuan

EqualOcean Analysis